Doseology Sciences Inc. (CSE: MOOD)

Market Cap	1.10M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	4.40M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.250
Previous Close	0.250
Day's Range	0.250 - 0.250
52-Week Range	0.070 - 0.660
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Doseology Sciences

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of nutraceutical products in Canada. The company offers medicinal mushroom products, including tinctures, powders, and herbal supplements to enhance health with a focus on mental health. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in Januar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MOOD